Skip to main content
. 2019 Apr 29;4(2):147–157. doi: 10.1016/j.jacbts.2018.12.005

Figure 5.

Figure 5

Tetralinoleoyl Cardiolipin With Elamipretide Treatment

(A) The effect of HF on tetralinoleoyl cardiolipin (mass-to-charge ratio, 1,448) in untreated samples is expressed as a percentage of total cardiolipin. Elamipretide-treated (B) NF hearts or (C) HF hearts showed no changes in tetralinoleoyl cardiolipin. Untreated hearts in B and C are shown with closed circles and treated hearts with open circles. NF, n = 5; HF, n = 10. Abbreviations as in Figure 1.